儿科疑似脓毒症早期乳酸水平与30天死亡率的相关性
该观察性队列研究纳入急诊科1299例疑似脓毒症患儿,分析首次静脉乳酸水平与30天院内死亡率的关系。结果显示乳酸>36 mg/dL与30天死亡率显著相关(校正OR 3.26,95%CI 1.16-9.16),但敏感性低(20.0%)。乳酸检测或有助于儿科脓毒症的早期风险分层。
要点
- 乳酸>36 mg/dL与30天死亡率独立相关,校正OR为3.26。
- 乳酸>36 mg/dL对30天死亡率敏感性低(20.0%),特异性高(92.3%)。
- 乳酸检测可能用于儿科脓毒症早期风险分层,但需结合临床。
核心结论
- 在急诊科治疗的疑似脓毒症患儿中,初始乳酸>36 mg/dL与30天死亡率相关,但敏感性低。
- 乳酸检测可能有助于儿科脓毒症的早期风险分层。
研究设计与样本
- 观察性队列研究,基于某三级儿童医院急诊科2012年4月1日至2015年12月31日的临床注册数据。
- 共纳入1299例疑似脓毒症患儿(男753例[58.0%],女546例[42.0%],平均年龄7.3[5.3]岁)。
- 暴露为到达后8小时内首次静脉乳酸>36 mg/dL,主要结局为30天院内死亡率。
主要发现
- 103例乳酸>36 mg/dL患儿中30天死亡5例(4.8%),1196例乳酸≤36 mg/dL患儿中死亡20例(1.7%)。
- 乳酸>36 mg/dL与30天死亡率未校正OR为3.00(95%CI 1.10-8.17),校正OR为3.26(95%CI 1.16-9.16)。
- 乳酸>36 mg/dL对30天死亡率的敏感性为20.0%(95%CI 8.9%-39.1%),特异性为92.3%(95%CI 90.7%-93.7%)。
临床怎么用
- 对急诊疑似脓毒症患儿,可考虑检测初始静脉乳酸以辅助早期风险分层。
- 乳酸>36 mg/dL提示死亡风险增高,但敏感性低,不能单独用于排除高风险。
局限性
- 研究为单中心观察性队列,可能存在残余混杂。
- 乳酸检测未强制,部分患儿因临床判断取消检测,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Improving emergency care of pediatric sepsis is a public health priority, but optimal early diagnostic approaches are unclear. Measurement of lactate levels is associated with improved outcomes in adult septic shock, but pediatric guidelines do not endorse its use, in part because the association between early lactate levels and mortality is unknown in pediatric sepsis. OBJECTIVE: To determine whether the initial serum lactate level is associated with 30-day mortality in children with suspected sepsis. DESIGN, SETTING, AND PARTICIPANTS: This observational cohort study of a clinical registry of pediatric patients with suspected sepsis in the emergency department of a tertiary children's hospital from April 1, 2012, to December 31, 2015, tested the hypothesis that a serum lactate level of greater than 36 mg/dL is associated with increased mortality compared with a serum lactate level of 36 mg/dL or less. Consecutive patients with sepsis were identified and included in the registry following consensus guidelines for clinical recognition (infection and decreased mental status or perfusion). Among 2520 registry visits, 1221 were excluded for transfer from another medical center, no measurement of lactate levels, and patients younger than 61 days or 18 years or older, leaving 1299 visits available for analysis. Lactate testing is prepopulated in the institutional sepsis order set but may be canceled at clinical discretion. EXPOSURES: Venous lactate level of greater than 36 mg/dL on the first measurement within the first 8 hours after arrival. MAIN OUTCOMES AND MEASURES: Thirty-day in-hospital mortality was the primary outcome. Odds ratios were calculated using logistic regression to account for potential confounders. RESULTS: Of the 1299 patients included in the analysis (753 boys [58.0%] and 546 girls [42.0%]; mean [SD] age, 7.3 [5.3] years), 899 (69.2%) had chronic medical conditions and 367 (28.3%) had acute organ dysfunction. Thirty-day mortality occurred in 5 of 103 patients (4.8%) with lactate levels greater than 36 mg/dL and 20 of 1196 patients (1.7%) with lactate levels of 36 mg/dL or less. Initial lactate levels of greater than 36 mg/dL were significantly associated with 30-day mortality in unadjusted (odds ratio, 3.00; 95% CI, 1.10-8.17) and adjusted (odds ratio, 3.26; 95% CI, 1.16- 9.16) analyses. The sensitivity of lactate levels greater than 36 mg/dL for 30-day mortality was 20.0% (95% CI, 8.9%-39.1%), and specificity was 92.3% (90.7%-93.7%). CONCLUSIONS AND RELEVANCE: In children treated for sepsis in the emergency department, lactate levels greater than 36 mg/dL were associated with mortality but had a low sensitivity. Measurement of lactate levels may have utility in early risk stratification of pediatric sepsis.
引用
- Scott HF, Brou L, Deakyne SJ, et al. Association Between Early Lactate Levels and 30-Day Mortality in Clinically Suspected Sepsis in Children. JAMA Pediatr. 2017. PMID: 28068437. doi:10.1001/jamapediatrics.2016.3681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。